Qiuyun Xu,Songyu Wang,Shuyi Shen et al.
Qiuyun Xu et al.
Response to Chen et al., "Comments on the increased risk of hidradenitis suppurativa in patients with human papillomavirus infection" [0.03%]
对陈等关于人乳头瘤病毒感染者汗腺炎发病风险增加评论的回应
Hui-Chin Chang,Shao-Wei Lo,Christine Hsu et al.
Hui-Chin Chang et al.
Comments on the increased risk of hidradenitis suppurativa in patients with human papillomavirus infection [0.03%]
人乳头瘤病毒感染患者发生汗腺炎的发病风险增加评论
Tai-Li Chen,Tsung-Hsien Chang
Tai-Li Chen
Risk of Major Adverse Cardiovascular Events and Venous Thromboembolic Events Between Patients With Psoriasis or Psoriatic Arthritis on Tumor Necrosis Factor Inhibitors, Interleukin-17 Inhibitors, Interleukin-12/23 Inhibitors and Interleukin-23 Inhibitors: An Emulated Target Trial Analysis [0.03%]
肿瘤坏死因子抑制剂、白细胞介素-17抑制剂、白细胞介素-12 / 23抑制剂和白细胞介素-23抑制剂治疗银屑病或银屑病关节炎患者的主要心血管事件和静脉血栓栓塞事件风险：模拟目标试验分析
Tai-Li Chen,Jing-Yang Huang,Hui-Yun Lin et al.
Tai-Li Chen et al.
Background: The risk of major adverse cardiovascular events (MACE) and venous thromboembolic events (VTE) in patients with psoriatic disease receiving biologics is not fully understood. ...
Rebecca L Quiñonez,Jasira Ziglar,Lydiah Fridah M Mpyisi et al.
Rebecca L Quiñonez et al.
Kevin J Severson,Hyun Witt,Shari A Ochoa
Kevin J Severson
The efficacy of longer-term lebrikizumab treatment in patients with moderate-to-severe atopic dermatitis who did not meet protocol-defined response criteria at week 16 in two randomized controlled clinical trials [0.03%]
利布瑞珠单抗长期治疗中重度特应性皮炎患者的有效性：两项随机临床试验中第16周未达到方案规定疗效标准的患者的后续结果
Emma Guttman-Yassky,David Rosmarin,Marjolein de Bruin-Weller et al.
Emma Guttman-Yassky et al.
Background: Lebrikizumab demonstrated statistically significant improvements in patients with moderate-to-severe atopic dermatitis at week 16 with a durable response up to week 52. ...
Disability and the Dermatology Patient- Part 2: Supporting Patients with Disabilities [0.03%]
皮肤病学患者的残疾问题（第二部分）：支持有残疾的患者
Sarah Kamsiah Zemlok,Sonal Muzumdar,Mary Wu Chang et al.
Sarah Kamsiah Zemlok et al.
Dermatologic disease can result in disability. In part two of this continuing medical education (CME) article, we highlight disabilities that may result from dermatologic conditions. We introduce guidelines for caring for patients with disa...
Disability and the Dermatology Patient- Part 1: Improving Access to Dermatologic Care [0.03%]
改善皮肤病学护理的获取（第一部分）——残疾人的皮肤科患者护理
Sonal Muzumdar,Sarah Kamsiah Zemlok,Brett Sloan et al.
Sonal Muzumdar et al.
Disability is common amongst dermatologic patients. Herein, we review the epidemiology of disability and terminology used to refer to patients with disabilities. We discuss different forms of disability, including cognitive, motor, visual a...
Timothy Klufas,Ayushya Ajmani,Albert E Zhou et al.
Timothy Klufas et al.